Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Penumbra Inc. (NYSE: PEN) is a key player in the treatment for ischemic stroke, having received FDA approval for the first aspiration-based thrombectomy system in 2007 and having since launched five new generations of…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A consulting team was just staffed on a PE due diligence project and needed to answer the question: “At what rate is business shifting to the cloud?”   GUIDEPOINT SOLUTION Guidepoint quickly vetted over 200 industry experts,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  Client Situation   A consulting team’s private equity due diligence engagement required them to quickly get up to speed on the molded rigid plastic packaging market. – Specifically the competitive landscape, differentiation, and pricing.   Guidepoint Solution Guidepoint quickly vetted…

Read More

Update on Business Immunity to COVID-19 Lawsuits

Guidepoint works with over 3,250 clients, including 9 of the top 10 global consulting firms.   Our network is made up of over 900,000 Advisors covering all sectors, regions and relevant industries. These Advisors are C-Suite Decision Makers, Customers, Suppliers,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Moodie Coretti, Director of Ecommerce, Pinnacle Foods The grocery industry is experiencing significant changes which are set to change the future of grocery shopping in the United States in the near and far future. The grocery disruption being felt…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Ken Wahl, Data Insights, Guidepoint Shire Plc’s (NYSE: SHPG) US hemophilia sales have faced much competition in recent years. In particular, their leading hemophilia A treatment Advate, an older, shorter-acting recombinant factor VIII, is facing many new US market…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Alicia Erdman, Founder and Principal, Wildwood Advisory Group Forecasts for retail have been particularly dire recently, with many news outlets anticipating a retail “apocalypse” as e-commerce continues to gain traction. However, performance on Black Friday and through the remainder…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Phillip Cooper, Pet Industry Expert and President, North American Sales & Marketing As the number of pet parents increase, individuals are doing more and spending more to take care of their “fur babies”. Whether they are buying the basics,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

Zimmer Biomet’s (NYSE: ZBH) US sales have declined every quarter since Q4 2016. After stating their expectations to make significant progress on remediating their supply issues during the first two quarters of 2017, Zimmer management was unable to meet those…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Alex Cohen, Chief, Commercial Specialist at Compass Between August 2016 and July 2017, only Amazon has leased more office space than WeWork in the United States. Though shared office spaces (office environments in which multiple firms sublet places to work within a single…

Read More